Article
An <i>in vivo</i> avian model of human melanoma to perform rapid and robust preclinical studies
2022-10-13
Abstract excerpt
Metastatic melanoma patients carrying a BRAF V600 mutation can be treated with BRAF inhibitors (BRAFi), in combination with MEK inhibitors (MEKi), but innate and acquired resistance invariably occurs. Resistance can involve transcriptional- and epigenetic-based phenotypic adaptations, as yet unpredictable. Predicting patient response to targeted therapies is crucial to guide clinical decision. We describe here th...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a0e2cef4-8896-5de0-b9fb-fee33947c508
- DOI
- 10.1101/2022.10.12.511927
